Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.
about
Identification of a hepatic factor capable of supporting hepatitis C virus replication in a nonpermissive cell lineRNA-dependent recruitment of the origin recognition complexEBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases.Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomesKaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomesEBNA1 partitions Epstein-Barr virus plasmids in yeast cells by attaching to human EBNA1-binding protein 2 on mitotic chromosomesThe EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfoldSimilarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a "Bookmarking" Oncoprotein that Alters the Host Cell Epigenotype?Crystal Structure of the Gamma-2 Herpesvirus LANA DNA Binding Domain Identifies Charged Surface Residues Which Impact Viral LatencyEpstein-Barr virus latent genesLEDGF/p75 proteins with alternative chromatin tethers are functional HIV-1 cofactorsInteraction between basic residues of Epstein-Barr virus EBNA1 protein and cellular chromatin mediates viral plasmid maintenance.Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.Conditional mutations in the mitotic chromosome binding function of the bovine papillomavirus type 1 E2 protein.Epstein-Barr virus nuclear antigen 1 does not induce lymphoma in transgenic FVB mice.Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenanceThe latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promotersThe replicator of the Epstein-Barr virus latent cycle origin of DNA replication, oriP, is composed of multiple functional elements.Epstein-Barr nuclear antigen 1 binds and destabilizes nucleosomes at the viral origin of latent DNA replication.Human DNA replication initiation factors, ORC and MCM, associate with oriP of Epstein-Barr virus.Epstein-Barr virus nuclear antigen 1 activates transcription from episomal but not integrated DNA and does not alter lymphocyte growthThe spacing between adjacent binding sites in the family of repeats affects the functions of Epstein-Barr nuclear antigen 1 in transcription activation and stable plasmid maintenanceUnexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems.Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication.Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells.Recent technological updates and clinical applications of induced pluripotent stem cellsDevelopment of a novel helper-dependent adenovirus-Epstein-Barr virus hybrid system for the stable transformation of mammalian cells.Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome.Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1Nuclear import of Epstein-Barr virus nuclear antigen 1 mediated by NPI-1 (Importin alpha5) is up- and down-regulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential.Mitotic chromosome-binding activity of latency-associated nuclear antigen 1 is required for DNA replication from terminal repeat sequence of Kaposi's sarcoma-associated herpesvirusEpisomal maintenance of plasmids with hybrid origins in mouse cellsThe Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episome persistenceRegulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylationFunctional modulation of the metastatic suppressor Nm23-H1 by oncogenic virusesEvaluating the potential of poly(beta-amino ester) nanoparticles for reprogramming human fibroblasts to become induced pluripotent stem cellsTranscriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.Improved elongation factor-1 alpha-based vectors for stable high-level expression of heterologous proteins in Chinese hamster ovary cells.
P2860
Q24291799-7B876C25-E323-41CC-AC55-187C203B9BF5Q24336965-7A8885F6-EEAE-4058-BB27-1FBA13A4CC04Q24529069-90A91275-48A5-4320-9AFE-90453C64F225Q24538878-AF5537A4-5A5B-4B24-9A4A-1B2AE25D5DC3Q24673761-2B8F6C9E-13C9-4F96-90F9-0B5638705D55Q24675498-E4828985-F778-4645-A81B-8262BB4747D5Q24685733-5D08D6FD-988E-4A8E-BD94-90FB360CCEFEQ26823342-BEC27A4D-033C-457C-A8BE-59A47BB84D80Q27680412-80283A02-2203-4F79-8A51-8060338548DAQ28082701-7B053804-DF3E-457E-A7F7-7A8112097C99Q28475761-3085EE40-5FAA-47CA-99F9-2015D98A380EQ30543103-3F8C3DAE-8D25-423C-A5A8-B97CE7CF1262Q33466782-EE245F9A-3A2E-4D1D-A564-36764E48DE14Q33598586-A776FED8-1965-4A41-928D-CDA14AFBA803Q33718255-3964CA99-15AF-4B75-98D8-53ED63E54E52Q33756914-01BB050D-A5ED-43ED-9CBB-6460B96B984EQ33786506-8E5AF03B-0B8C-45DC-B850-5FD5E02878CAQ33845947-BF1144D8-F563-4381-B00F-EBDB9391F0D5Q33848552-FCFB5F1A-6B08-4A79-863C-109805386A2AQ33941808-6991F905-F004-4365-BE71-0A967C98F50BQ33942957-756E08C1-BFD6-49FD-AC25-51A15CF7E184Q33953070-06757F1C-2E45-4384-9578-24B2223693E3Q34067438-B37BAD04-E3BC-45CD-A819-536C2C6C9582Q34082799-96BA1944-86B1-406D-AAEA-CA03AB827594Q34128791-F0CE94BC-09FE-4F29-BBF1-227B98E239E7Q34142823-B833A12C-1822-4CE0-BF32-70C13A24D65DQ34184553-25D357F5-5095-42F9-9D7F-823E81FBE1B0Q34193804-A6C74298-05FE-4D43-88DB-BE1A52B56085Q34332147-7796A110-9E3F-4A62-A1E7-625F3ACB2881Q34348453-261D88C3-C882-488F-95A3-5E0D2F940AFDQ34350776-A3C9E795-FFAD-40EF-A274-258DD30D2C44Q34353280-C1C2A499-ECE3-4540-84AC-33766C05AFC6Q34437977-085CD9F8-82A3-46EE-9D84-AD146ACCDF00Q34470031-29743B03-C1E7-4A75-B43D-4610ECBCADDBQ34553975-5027FD44-452B-4DEA-8383-AD694A9E34C7Q34648403-265316AC-E4D1-47A3-BEF2-D03FB818243AQ34901718-BC90E06A-B172-4D1D-A293-AB5B51B8B585Q35069104-84CAF177-365F-4248-80E7-642B06B3BDCFQ35080523-BBFDD501-6029-4BD8-BD9A-BB7EA9C9C853Q35188321-81BA2AA1-D400-4CA1-BD89-EC374E535A34
P2860
Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@ast
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@en
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@nl
type
label
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@ast
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@en
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@nl
prefLabel
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@ast
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@en
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@nl
P2860
P356
P1476
Maintenance of Epstein-Barr vi ...... obility group-I or histone H1.
@en
P2093
P2860
P304
P356
10.1073/PNAS.031584698
P407
P577
2001-02-06T00:00:00Z